Lung Cancer Treatment Options And Outcomes - information resource for patients

This report is specific for Lung Cancer. 
This 44 page report has 9 sections, which includes basic explanation of the disease state, 5-year survival rate, basic outline of current therapeutic approaches, information on 36 FDA-approved drugs for non-small cell lung cancer (NSCLC) and small cell lung cancer, outline of the mechanism of action for each drug, outcome of clinical trials measured as response rate, median overall survival and disease progression-free survival, ongoing clinical trials, information on support groups and list of other credible resources to support your own research. Now cancer patients do not have to spend hours online trying to find credible information. With this information summary, cancer patients can make informed decisions together with their doctors. It matters where you get your information from.